Additionally, as per a study conducted by the Indian Council of Medical Research spanning 4 Indian states namely Tamil Nadu, Maharashtra, Jharkhand and Chandigarh, 62.4 million people in India are afflicted with diabetes and another 77.2 million with pre-diabetes, reiterating the fact that India is the 'World's Diabetes Capital'.
It has been inferred that 30% of the total number patients screened have been labeled with abnormal glucose levels. Additionally it has been observed that 40% of the diabetic patients have been able to maintain satisfactory sugar levels as compared to the remaining 60 % with peculiarly high glucose levels.
In addition, the data highlights the fact that women in Mumbai are equally prone to diabetes as compared to men in Mumbai. In Chandigarh, Pune, Bangalore & Chennai it has been observed that diabetes is predominant in males over females in the same age group i.e., ratio is 60 : 40 where the former is for males and latter for females. The inferences indicate that a similar pattern of abnormality in sugar levels has been noticed in west, south and north India.
Commenting on the survey, Dr. Mrs. Jatinder Bhatia, Chief of Lab Services, Projects – North India, Metropolis Healthcare Ltd said, “The incidence of diabetes is increasing in India affecting both males and females equally. Younger age groups too are falling easy prey to diabetes. This unhealthy trend is a direct result of a combination of over-eating, junk food and sedentary lifestyle. She further added that it is imperative for diabetic patients to get basic testing such as HbA1C Glycated Haemoglobin, Fasting Blood Glucose and Postprandial Blood Glucose & Micro Albumin Uria at regular intervals i.e. every 3 months.”
Individuals have become more aware of the fact that diabetes is not just a disease of the elderly and are now a lot more determined to go a long-way in combating this chronic ailment. Calling for regular screening of unhealthy glucose levels, researchers at Metropolis said surveys such as the one conducted would help identify people who are at a greater risk of diabetes.
About Metropolis Healthcare
Metropolis Healthcare Ltd. was founded by Dr. Sushil Shah in 1981. The Board of Directors include Dr. Sushil Shah, Metropolis Healthcare is one of the India’s leading multinational chain of diagnostic centers across India, Sri Lanka, Bangladesh, Nepal, South Africa and Middle East. It provides around 4500 specialized tests under a single roof ranging from oncology to genetics, molecular biology and immunoassays using best-of-breed and latest diagnostic equipment. Metropolis Healthcare Ltd has also been recently voted as the sole recipient for the Frost & Sullivan - 2010 India Excellence in Healthcare Awards - Diagnostic Services Company of the Year. Ms. Ameera Shah has won prestigious award in 2nd CMO Asia Award as Young Achiever of the year'2011 & Franchisee India - Young Entrepreneur of the year 2011.eHealth World Expo 2011 – has also awarded Metropolis Healthcare Ltd as “Best Jury Award” for ICT enabled diagnostic service provider for the project IT integration of customer service management.
Warburg Pincus, a leading global private equity firm, has recently invested up to $85 million in Metropolis Healthcare Ltd. With 65 State of Art laboratories, Metropolis is a preferred referral center for more than 10000 laboratories, clinicians, hospitals and research institutions across 125 cities India. The CAP, US FDA for the SMO services, NABL accredited and ISO 15189 certified Metropolis chain of laboratories has over 550 collection centers and is a preferred laboratory for providing quality testing to over 50, 000 Doctors across the country. Services include Clinical Referral Laboratory Hospital Laboratory Management, Preventive Health Checkups, Home Health Services, Site Management Services and Clinical Trials.
